Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 11 to 20 of 20

Guidance and quality standards in consultation
TitleConsultationTypeConsultation end date
Brentuximab vedotin with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone for untreated advanced classical Hodgkin lymphoma [ID6437]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac deathDraft scope consultationInterventional procedures guidance
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitors (review of TA881) [ID6496]Final draft guidanceTechnology appraisal guidance
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]Final draft guidanceTechnology appraisal guidance
Norucholic acid for treating primary sclerosing cholangitis [ID6583]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Acalabrutinib and venetoclax with or without obinutuzumab for untreated chronic lymphocytic leukaemia [ID6232]Draft guidanceTechnology appraisal guidance
Pegcetacoplan for treating complement 3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]Draft guidanceTechnology appraisal guidance
Bepirovirsen for treating chronic hepatitis B [ID6608]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Gender Incongruence Services for Children and Young PeopleTopic engagementQuality standard
Rebisufligene etisparvovec for treating mucopolysaccharidosis type IIIA [ID6540]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All